Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 37,000 | 40,000 | 37,000 | 34,000 | 42,000 |
| Operating Revenue | 37,000 | 40,000 | 37,000 | 34,000 | 42,000 |
| Gross Profit | -- | -- | -- | -- | -- |
| Selling General And Administration | 902,000 | 504,000 | 44,000 | 83,000 | 92,000 |
| General And Administrative Expense | 902,000 | 504,000 | 44,000 | 83,000 | 92,000 |
| Other Operating Expenses | 614,000 | 27,000 | 65,000 | 3,000 | 6,000 |
| Operating Expense | 1.5M | 539,000 | 129,000 | 105,000 | 116,000 |
| Operating Income | -1.5M | -499,000 | -92,000 | -71,000 | -74,000 |
| EBIT | -560,000 | -427,000 | -2.0M | -15.5M | -74,000 |
| Interest Expense | 2,000 | 13,000 | 21,000 | 22,000 | 23,000 |
| Interest Expense Non Operating | 2,000 | 13,000 | 21,000 | 22,000 | 23,000 |
| Interest Income | 5,000 | 2,000 | 0.00 | 0.00 | 0.00 |
| Interest Income Non Operating | 5,000 | 2,000 | 0.00 | 0.00 | 0.00 |
| Net Interest Income | 3,000 | -11,000 | -21,000 | -22,000 | -23,000 |
| Other Income Expense | 922,000 | 70,000 | -1.9M | -15.4M | -- |
| Other Non Operating Income Expenses | 921,000 | -- | -- | -- | -- |
| Special Income Charges | 0.00 | 70,000 | -1.9M | -15.4M | 0.00 |
| Gain On Sale Of Security | 1,000 | -- | -- | -- | -- |
| Pretax Income | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Net Income From Continuing Operation Net Minority Interest | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Net Income Including Noncontrolling Interests | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Net Income Common Stockholders | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Net Income | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| EBITDA | -552,000 | -419,000 | -2.0M | -15.5M | -55,000 |
| Normalized EBITDA | -553,000 | -489,000 | -72,000 | -52,000 | -55,000 |
| Reconciled Depreciation | 8,000 | 8,000 | 20,000 | 18,000 | 19,000 |
| Basic EPS | -0.01 | -0.03 | -- | -1.50 | -0.01 |
| Diluted EPS | -0.01 | -0.03 | -- | -1.50 | -0.01 |
| Basic Average Shares | 39.3M | 16.3M | -- | 10.2M | 10.2M |
| Diluted Average Shares | 39.3M | 16.3M | -- | 10.2M | 10.2M |
| Total Unusual Items | 1,000 | 70,000 | -1.9M | -15.4M | 0.00 |
| Total Unusual Items Excluding Goodwill | 1,000 | 70,000 | -1.9M | -15.4M | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -563,000 | -510,000 | -113,000 | -93,000 | -97,000 |
| Depletion Income Statement | 8,000 | 8,000 | 20,000 | 19,000 | 18,000 |
| Depreciation Amortization Depletion Income Statement | 8,000 | 8,000 | 20,000 | 19,000 | 18,000 |
| Diluted NI Availto Com Stockholders | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Impairment Of Capital Assets | 0.00 | 0.00 | 1.8M | 15.4M | 0.00 |
| Net Income Continuous Operations | -562,000 | -440,000 | -2.0M | -15.5M | -97,000 |
| Net Non Operating Interest Income Expense | 3,000 | -11,000 | -21,000 | -22,000 | -23,000 |
| Other Gand A | 338,000 | 504,000 | 44,000 | 83,000 | 92,000 |
| Other Special Charges | -- | -70,000 | -- | -- | -- |
| Salaries And Wages | 564,000 | -- | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1.5M | 539,000 | 129,000 | 105,000 | 116,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 618,000 | 1.0M | 12,000 | 74,000 | 70,000 |
| Cash Cash Equivalents And Short Term Investments | 618,000 | 1.0M | 12,000 | 74,000 | 70,000 |
| Cash Financial | 618,000 | 1.0M | 12,000 | 74,000 | 70,000 |
| Accounts Receivable | 57,000 | 67,000 | 28,000 | 61,000 | 59,000 |
| Receivables | 57,000 | 67,000 | 28,000 | 61,000 | 59,000 |
| Prepaid Assets | 151,000 | 139,000 | 8,000 | 3,000 | 4,000 |
| Current Assets | 826,000 | 1.2M | 48,000 | 138,000 | 133,000 |
| Gross PPE | 408,000 | 408,000 | 408,000 | 1.3M | 16.4M |
| Accumulated Depreciation | -171,000 | -163,000 | -155,000 | -127,000 | -109,000 |
| Net PPE | 237,000 | 245,000 | 253,000 | 1.1M | 16.3M |
| Total Non Current Assets | 237,000 | 245,000 | 253,000 | 1.1M | 16.3M |
| Total Assets | 1.1M | 1.5M | 301,000 | 1.3M | 16.4M |
| Current Debt | 285,000 | 281,000 | 987,000 | 475,000 | 475,000 |
| Current Debt And Capital Lease Obligation | 285,000 | 281,000 | 987,000 | 475,000 | 475,000 |
| Payables And Accrued Expenses | 183,000 | 1.2M | 1.5M | 1.4M | 1.1M |
| Current Liabilities | 1.6M | 2.1M | 3.1M | 2.0M | 1.7M |
| Long Term Debt | -- | -- | -- | 577,000 | 114,000 |
| Long Term Debt And Capital Lease Obligation | -- | -- | -- | 577,000 | 114,000 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 702,000 | 655,000 |
| Total Liabilities Net Minority Interest | 1.6M | 2.1M | 3.1M | 2.7M | 2.4M |
| Common Stock | 39.3M | 39.3M | 36.9M | 36.9M | 36.9M |
| Capital Stock | 39.3M | 39.3M | 36.9M | 36.9M | 36.9M |
| Retained Earnings | -50.7M | -50.1M | -49.6M | -47.7M | -32.2M |
| Gains Losses Not Affecting Retained Earnings | 10.7M | 10.2M | 10.0M | 9.4M | 9.4M |
| Other Equity Adjustments | 10.7M | 10.2M | 10.0M | 9.4M | 9.4M |
| Common Stock Equity | -574,000 | -608,000 | -2.8M | -1.4M | 14.1M |
| Stockholders Equity | -574,000 | -608,000 | -2.8M | -1.4M | 14.1M |
| Total Equity Gross Minority Interest | -574,000 | -608,000 | -2.8M | -1.4M | 14.1M |
| Total Capitalization | -574,000 | -608,000 | -2.8M | -815,000 | 14.2M |
| Net Tangible Assets | -574,000 | -608,000 | -2.8M | -1.4M | 14.1M |
| Tangible Book Value | -574,000 | -608,000 | -2.8M | -1.4M | 14.1M |
| Working Capital | -811,000 | -853,000 | -3.1M | -1.8M | -1.6M |
| Invested Capital | -289,000 | -327,000 | -1.8M | -340,000 | 14.7M |
| Total Debt | 285,000 | 281,000 | 987,000 | 1.1M | 589,000 |
| Net Debt | -- | -- | 975,000 | 978,000 | 519,000 |
| Share Issued | 39.5M | 39.1M | 10.2M | 10.2M | 10.2M |
| Ordinary Shares Number | 39.5M | 39.1M | 10.2M | 10.2M | 10.2M |
| Current Provisions | 1.2M | 573,000 | 604,000 | 108,000 | 101,000 |
| Line Of Credit | 285,000 | 281,000 | 512,000 | -- | -- |
| Long Term Provisions | -- | -- | -- | 125,000 | 541,000 |
| Other Current Borrowings | -- | -- | 475,000 | 475,000 | 475,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -385,000 | -500,000 | 15,000 | -8,000 | -19,000 |
| Cash Flow From Continuing Operating Activities | -386,000 | -500,000 | 15,000 | -8,000 | -19,000 |
| Depreciation Amortization Depletion | 8,000 | 8,000 | 20,000 | 18,000 | 19,000 |
| Stock Based Compensation | -- | -- | 0.00 | 0.00 | 0.00 |
| Change In Working Capital | -97,000 | -259,000 | 164,000 | 18,000 | 85,000 |
| Change In Receivables | 10,000 | -39,000 | 29,000 | -2,000 | 6,000 |
| Change In Payables And Accrued Expense | -95,000 | -89,000 | 140,000 | 19,000 | 75,000 |
| Other Non Cash Items | -254,000 | 80,000 | -25,000 | 14,000 | 9,000 |
| Purchase Of PPE | -- | -- | 0.00 | 0.00 | 0.00 |
| Net PPE Purchase And Sale | -- | -- | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance Of Debt | -- | -- | 0.00 | 0.00 | -- |
| Repayment Of Debt | 0.00 | -231,000 | -- | -- | 0.00 |
| Net Issuance Payments Of Debt | 0.00 | -231,000 | -65,000 | 0.00 | 0.00 |
| Issuance Of Capital Stock | 0.00 | 2.0M | -- | -- | 0.00 |
| Net Common Stock Issuance | 0.00 | 2.0M | -- | -- | 0.00 |
| Financing Cash Flow | 0.00 | 1.5M | -65,000 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | 1.5M | -65,000 | 0.00 | 0.00 |
| Effect Of Exchange Rate Changes | -- | -- | -12,000 | 12,000 | -- |
| Changes In Cash | -385,000 | 991,000 | -50,000 | -8,000 | -19,000 |
| Beginning Cash Position | 1.0M | 12,000 | 74,000 | 70,000 | 89,000 |
| End Cash Position | 618,000 | 1.0M | 12,000 | 74,000 | 70,000 |
| Free Cash Flow | -385,000 | -500,000 | 15,000 | -8,000 | -19,000 |
| Asset Impairment Charge | 0.00 | 0.00 | 1.8M | 15.4M | -36,000 |
| Change In Prepaid Assets | -12,000 | -131,000 | -5,000 | 1,000 | 4,000 |
| Common Stock Issuance | 0.00 | 2.0M | -- | -- | 0.00 |
| Depletion | 8,000 | 8,000 | 20,000 | 18,000 | 19,000 |
| Long Term Debt Issuance | -- | -- | -- | 0.00 | -- |
| Net Foreign Currency Exchange Gain Loss | -44,000 | 111,000 | -- | -- | 0.00 |
| Net Income From Continuing Operations | -563,000 | -440,000 | -2.0M | -15.5M | -96,000 |
| Net Long Term Debt Issuance | -- | -- | -65,000 | 0.00 | -- |
| Net Other Financing Charges | 0.00 | -264,000 | -- | -- | -- |
| Net Short Term Debt Issuance | 0.00 | -231,000 | 0.00 | 0.00 | 0.00 |
| Operating Gains Losses | -44,000 | 111,000 | -- | -- | -- |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 0.00 | 0.00 |
| Short Term Debt Issuance | -- | -- | 0.00 | -- | -- |
| Short Term Debt Payments | 0.00 | -231,000 | -- | -- | 0.00 |